MedPath

Management Arterial Hypotension During Planned Caesarean Section, Intravenous Ephedrine/Phenylephrine Mixture Versus Intravenous Baby Noradrenaline

Conditions
Hypotension
Registration Number
NCT05513066
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

Comparison of two practices of obstetrical services between the CHU of Clermont Ferrand and the HFME Lyon-Bron in the management of arterial hypotension during an elective cesarean section

Detailed Description

The investigators propose to carry out a bicentric strict observational prospective study between the maternity of the HFME of Lyon-Bron which uses the mixture ephedrine / noradrenaline with the PSE for many years in service protocol for the management of hypotension for cesarean section under perimedullary anesthesia and the CHU of Clermont-Ferrand which uses baby noradrenaline 10 mcg/mL PSE for this same indication according to an institutional protocol. Patients corresponding to the inclusion and non-inclusion criteria will be recruited by a physician investigator and will give their agreement of non-opposition after having received clear oral and written information about our study. The care will not be modified in any way compared to the usual practices of the service.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
300
Inclusion Criteria
  • elective caesarean
  • ≥ 18 years old
  • term ≥ 36 weeks amenorrhea
Exclusion Criteria
  • contraindication of local anesthetics
  • contraindication of spinal anesthesia
  • patient's refusal
  • patient doesn't talk French
  • patient not covered by the social security system

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Systolic blood pressureduration of the procedure up to one hour

Time-weighted mean intraoperative systolic blood pressure below a threshold of 80mmHg, 90mmHg and 100mmHg. This measurement is commonly called TWA (time weighted average), corresponding to the area between the chosen PAS threshold and the curve of the measured PAS, divided by the total time of the measurements. Blood pressure will be measured by the Clearsight system, absolutely non-invasive continuous pulse wave contour monitoring.

Secondary Outcome Measures
NameTimeMethod
Clinical sign of hypotensionduration of the procedure up to one hour

nausea, vomiting, faint

crystalloidsduration of the procedure up to one hour

volume of crystalloids infused

Foetal pHat birth

arterial and venous

total diuresisduration of the procedure up to one hour
boli of vasopressorduration of the procedure up to one hour

appeal to boli of ephedrine and/or phenylephrine and/or noradrenaline

boli of atropineduration of the procedure up to one hour

appeal to boli of atropine

intrathecal local anestheticsduration of the procedure up to one hour

amount of intrathecal local anesthetics injected

Trial Locations

Locations (2)

CHU clermont-ferrand

🇫🇷

Clermont-Ferrand, France

Hospices Civils de Lyon

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath